Moyamoya syndrome may result from psoriasis: Four case reports

Table 1 Demographic characteristics

Items	Gender	Age of developing psoriasis (age)	Age at MMS-related stroke (age)	Duration of hypertension (yr)	Blood pressure at admission (mmHg)	Type of stroke	NIHSS on admission 0-42	Suzuki grade I-VI	mRS on admission 0-5
Case 1	Male	30	42	-	120/70	ICH	2	III	2
Case 2	Male	52	71	3	122/68	TIA	0	V	0
Case 3	Female	30	47	2	140/88↑	ICH	2	IV	2
Case 4	Male	35	65	3	190/100↑	ICH	1	IV	1

MMS: Moyamoya syndrome; NIHSS: National Institute of Health stroke scale; mRS: Modified Rankin scale; ICH: Intracerebral hemorrhage; TIA: Transient ischemic attack.

Table 2 Data of blood tests

Items	White blood cell (4-10, × 109/L)	Neutrophils (1.8-3.6, × 109/L)	Monocytes (0.1-0.6, × 109/L)	Platelet (100-300, × 109/L)	Interleukin-4 (0-3, pg/mL)	Interleukin-6 (0-5.3, pg/mL)	Immunoglobulin E (0-40, mg/L)	Treg cells (CD4+) (2.86-7.74, %)	Cholesterol (2.8-5.2, mmol/L)	LDL cholesterol (1.6-3.4, mmol/L)
Case 1	9.38	5.57	0.63↑	203	1.09	8.27↑	90.8↑	-	5.76↑	4.15↑
Case 2	7.67	4.95	0.51	244	1.22	7.63↑	68.9↑	-	4.04	3.18
Case 3	6.92	4.32	0.5	358↑	3.43	8.49↑	17.8	11.4↑	4.88	3.36
Case 4	9.4	7.5	0.74↑	338↑	0.35	8.86↑	16.9	-	4.84	2.44

The arrows indicated that the results were over the normal cutoff value.